LETTERS TO THE EDITOR

Clinical Therapeutics welcomes letters to the Editor that comment on articles published by the journal within the last 12 months. Letters must be typed double-spaced and signed by no more than 5 authors. Financial associations and other conflicts of interest must be disclosed. All letters are subject to editing. The corresponding author’s full name, affiliation, mailing address, and telephone and fax numbers must be included.

Manuscripts and editorial correspondence should be addressed as follows:

Philip D. Walson, MD
Editor-in-Chief
Clinical Therapeutics
Excerpta Medica, Inc.
685 Route 202/206
Bridgewater, NJ 08807
USA
ClinTher@elsevier.com

Copyright © Excerpta Medica, Inc.